Xeomin 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FC1PZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,467
Award facts
- Contract value 100% obligated
- $23,467.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,467.08 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials. This firm fixed-price delivery order, issued on November 12, 2025, will be completed by December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Conshohocken, Pennsylvania, with an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company demonstrates significant capability in fulfilling diverse federal medical supply needs through open competition, with prior delivery orders ranging from under $100 to over $45,000. Xeomin, a botulinum toxin product, may be procured for medical or therapeutic applications within the Defense Health Agency or other military healthcare systems supported through the DLA's comprehensive pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB26FC1PZ?
SPE2DB26FC1PZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FC1PZ worth?
The government has obligated $23,467 on SPE2DB26FC1PZ.
Is contract SPE2DB26FC1PZ an order under another contract?
Yes. SPE2DB26FC1PZ is a delivery order under SPE2DB20D7066, an indefinite delivery contract.
Was contract SPE2DB26FC1PZ competed?
The extent of competition for SPE2DB26FC1PZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award